Weight management to BMI 22-24

Suggested

2 studies · 1 recommendation

Last updated: February 2, 2026

Weight management to BMI 22-24 – Obesity
Suggested2 studies

Maintaining BMI 22-24 minimizes mortality risk and supports metabolic health in obesity

Evidence from 2 studies including a meta-analysis of 230 cohort studies with 30.3 million participants and 3.74 million deaths establishes BMI 22-24 as the optimal target range for weight management. Among never smokers, each 5-unit BMI increase above this range raises all-cause mortality by 18-27%, with the lowest mortality observed at BMI 23-24 in general populations and BMI 20-22 in long-term follow-up exceeding 20 years. European clinical guidelines confirm that balanced hypocaloric diets produce clinically meaningful weight loss regardless of macronutrient composition. The guidelines recognize obesity as a chronic metabolic disease where realistic weight reduction targets—specifically achieving BMI within the 22-24 range—effectively reduce cardiovascular and metabolic disease risks associated with excess intra-abdominal fat accumulation.

Evidence

Authors: Aune, D, Janszky, I, Norat, T, Prasad, M, Romundstad, P, Sen, A, Tonstad, S, Vatten, LJ

Published: January 1, 2016

Meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. Among never smokers (53 studies, >738,144 deaths, >9.98 million participants), each 5-unit BMI increment increased mortality risk by 18% (RR 1.18, 95% CI 1.15-1.21). In healthy never smokers (25 studies), the risk increased to 21% per 5 BMI units (RR 1.21, 95% CI 1.18-1.25). With exclusion of early follow-up (11 studies), risk rose to 27% per 5 BMI units (RR 1.27, 95% CI 1.21-1.33). Lowest mortality observed at BMI 23-24 in never smokers, 22-23 in healthy never smokers, and 20-22 with ≥20 years follow-up (P for non-linearity <0.001).

Authors: Busetto, Luca, Fried, Martin, Micic, Dragan, Schindler, Karin, Toplak, Hermann, Tsigos, Constantine, Yumuk, Volkan

Published: January 1, 2015

European clinical guidelines for obesity management establish that balanced hypocaloric diets result in clinically meaningful weight loss regardless of which macronutrients they emphasize. This recommendation forms part of comprehensive evidence-based treatment guidelines developed for adults with obesity, defined as a chronic metabolic disease characterized by increased body fat stores. The guidelines emphasize realistic weight loss goals aimed at reducing health risks associated with excess body fat and intra-abdominal fat accumulation, which serves as a marker for higher metabolic and cardiovascular disease risk.